Joby Aviation closes $591 million stock offering with full underwriter option
Director Gregg Williams of Vivani Medical, Inc. (NASDAQ:VANI) acquired a total of 2,068,453 shares of common stock on September 15, 2025, in a series of transactions. The prices for these purchases ranged from $1.12 to $1.26. The stock, currently trading at $1.42, has shown significant volatility according to InvestingPro data, with a 52-week range of $0.91 to $1.80.
Williams purchased 1,473,215 shares at $1.12, for a total value of $1,650,000. Additionally, he acquired 595,238 shares at $1.26, totaling $749,999. With a market capitalization of $84.1 million and analysts setting a $4.00 price target, this insider purchase comes as InvestingPro analysis indicates the company is rapidly burning through cash. Get access to 5 more exclusive ProTips and detailed financial metrics with InvestingPro.
Following these transactions, Williams directly owns 4,799,200 shares and indirectly owns 15,909,348 shares of Vivani Medical, Inc. common stock.
In other recent news, Vivani Medical announced plans to begin a Phase 1 clinical trial for its semaglutide implant, NPM-139, aimed at chronic weight management. The trial is expected to commence in the first half of 2026, pending regulatory approval. Additionally, Vivani Medical has secured $10 million in equity financing to further develop the semaglutide implant. This funding, which involves an investment from an entity owned by the company’s Chairman Gregg Williams, ensures financial stability through the latter half of 2026. H.C. Wainwright has maintained a Buy rating on Vivani Medical, setting a price target of $4.00, following the announcement of these clinical development plans. The firm highlighted the potential of the semaglutide implant in addressing obesity and related comorbidities. In other developments, Vivani Medical’s shareholders elected all six board nominees during the company’s 2025 Annual Meeting of Stockholders. This meeting saw 37,097,099 shares represented, establishing a quorum for decision-making.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.